Annual Net Income
-$117.17 M
+$37.37 M+24.18%
31 December 2023
Summary:
Adverum Biotechnologies annual net profit is currently -$117.17 million, with the most recent change of +$37.37 million (+24.18%) on 31 December 2023. During the last 3 years, it has risen by +$342.00 thousand (+0.29%). ADVM annual net income is now -6369.63% below its all-time high of -$1.81 million, reached on 31 December 2012.ADVM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$27.13 M
-$8.66 M-46.86%
30 September 2024
Summary:
Adverum Biotechnologies quarterly net profit is currently -$27.13 million, with the most recent change of -$8.66 million (-46.86%) on 30 September 2024. Over the past year, it has increased by +$5.75 million (+17.49%). ADVM quarterly net income is now -55275.51% below its all-time high of -$49.00 thousand, reached on 31 March 2013.ADVM Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$94.11 M
+$5.75 M+5.76%
30 September 2024
Summary:
Adverum Biotechnologies TTM net profit is currently -$94.11 million, with the most recent change of +$5.75 million (+5.76%) on 30 September 2024. Over the past year, it has increased by +$32.08 million (+25.42%). ADVM TTM net income is now -191963.27% below its all-time high of -$49.00 thousand, reached on 31 March 2013.ADVM TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ADVM Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +24.2% | +17.5% | +25.4% |
| 3 y3 years | +0.3% | +29.3% | +36.7% |
| 5 y5 years | -61.3% | -68.3% | -53.7% |
ADVM Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +24.2% | -46.9% | +38.0% | at high | +39.8% |
| 5 y | 5 years | -81.7% | +24.2% | -68.3% | +38.8% | -53.7% | +39.8% |
| alltime | all time | -6369.6% | +24.2% | <-9999.0% | +56.0% | <-9999.0% | +39.8% |
Adverum Biotechnologies Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$27.13 M(+46.9%) | -$94.11 M(-5.8%) |
| June 2024 | - | -$18.48 M(-25.5%) | -$99.86 M(-11.5%) |
| Mar 2024 | - | -$24.79 M(+4.5%) | -$112.90 M(-3.6%) |
| Dec 2023 | -$117.17 M(-24.2%) | -$23.71 M(-27.9%) | -$117.17 M(-7.1%) |
| Sept 2023 | - | -$32.88 M(+4.4%) | -$126.19 M(-5.4%) |
| June 2023 | - | -$31.51 M(+8.4%) | -$133.43 M(-8.4%) |
| Mar 2023 | - | -$29.06 M(-11.2%) | -$145.68 M(-5.7%) |
| Dec 2022 | -$154.54 M(+6.2%) | -$32.74 M(-18.4%) | -$154.54 M(-1.1%) |
| Sept 2022 | - | -$40.13 M(-8.3%) | -$156.21 M(+1.1%) |
| June 2022 | - | -$43.76 M(+15.4%) | -$154.44 M(-0.4%) |
| Mar 2022 | - | -$37.91 M(+10.2%) | -$155.01 M(+6.5%) |
| Dec 2021 | -$145.54 M(+23.9%) | -$34.41 M(-10.3%) | -$145.54 M(-2.2%) |
| Sept 2021 | - | -$38.36 M(-13.5%) | -$148.76 M(+7.7%) |
| June 2021 | - | -$44.33 M(+55.9%) | -$138.17 M(+12.3%) |
| Mar 2021 | - | -$28.44 M(-24.4%) | -$123.04 M(+4.7%) |
| Dec 2020 | -$117.51 M(+82.2%) | -$37.63 M(+35.5%) | -$117.51 M(+18.9%) |
| Sept 2020 | - | -$27.77 M(-4.9%) | -$98.80 M(+13.4%) |
| June 2020 | - | -$29.20 M(+27.5%) | -$87.15 M(+19.5%) |
| Mar 2020 | - | -$22.91 M(+21.0%) | -$72.90 M(+13.1%) |
| Dec 2019 | -$64.49 M(-11.2%) | -$18.93 M(+17.4%) | -$64.49 M(+5.3%) |
| Sept 2019 | - | -$16.12 M(+7.8%) | -$61.22 M(-7.3%) |
| June 2019 | - | -$14.95 M(+3.2%) | -$66.06 M(-5.5%) |
| Mar 2019 | - | -$14.49 M(-7.5%) | -$69.92 M(-3.7%) |
| Dec 2018 | -$72.63 M | -$15.66 M(-25.3%) | -$72.63 M(+1.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2018 | - | -$20.96 M(+11.4%) | -$71.76 M(+11.0%) |
| June 2018 | - | -$18.81 M(+9.4%) | -$64.63 M(+12.9%) |
| Mar 2018 | - | -$17.20 M(+16.3%) | -$57.25 M(+2.0%) |
| Dec 2017 | -$56.15 M(-50.6%) | -$14.79 M(+6.9%) | -$56.15 M(-11.9%) |
| Sept 2017 | - | -$13.83 M(+21.0%) | -$63.75 M(-0.7%) |
| June 2017 | - | -$11.43 M(-29.0%) | -$64.22 M(-43.9%) |
| Mar 2017 | - | -$16.10 M(-28.1%) | -$114.45 M(+0.6%) |
| Dec 2016 | -$113.75 M(+139.7%) | -$22.39 M(+56.6%) | -$113.75 M(+7.9%) |
| Sept 2016 | - | -$14.30 M(-76.8%) | -$105.45 M(+0.2%) |
| June 2016 | - | -$61.66 M(+300.6%) | -$105.23 M(+97.3%) |
| Mar 2016 | - | -$15.39 M(+9.2%) | -$53.34 M(+12.4%) |
| Dec 2015 | -$47.45 M(+86.8%) | -$14.09 M(+0.1%) | -$47.45 M(+8.5%) |
| Sept 2015 | - | -$14.08 M(+44.2%) | -$43.75 M(+15.4%) |
| June 2015 | - | -$9.77 M(+2.7%) | -$37.92 M(+14.1%) |
| Mar 2015 | - | -$9.51 M(-8.5%) | -$33.25 M(+30.9%) |
| Dec 2014 | -$25.40 M(+381.5%) | -$10.39 M(+25.9%) | -$25.40 M(+35.8%) |
| Sept 2014 | - | -$8.26 M(+62.1%) | -$18.71 M(+66.1%) |
| June 2014 | - | -$5.09 M(+206.3%) | -$11.26 M(+63.5%) |
| Mar 2014 | - | -$1.66 M(-55.0%) | -$6.89 M(+30.6%) |
| Dec 2013 | -$5.28 M(+191.3%) | -$3.69 M(+354.2%) | -$5.28 M(+233.3%) |
| Sept 2013 | - | -$813.00 K(+12.8%) | -$1.58 M(+105.6%) |
| June 2013 | - | -$721.00 K(+1371.4%) | -$770.00 K(+1471.4%) |
| Mar 2013 | - | -$49.00 K | -$49.00 K |
| Dec 2012 | -$1.81 M | - | - |
FAQ
- What is Adverum Biotechnologies annual net profit?
- What is the all time high annual net income for Adverum Biotechnologies?
- What is Adverum Biotechnologies annual net income year-on-year change?
- What is Adverum Biotechnologies quarterly net profit?
- What is the all time high quarterly net income for Adverum Biotechnologies?
- What is Adverum Biotechnologies quarterly net income year-on-year change?
- What is Adverum Biotechnologies TTM net profit?
- What is the all time high TTM net income for Adverum Biotechnologies?
- What is Adverum Biotechnologies TTM net income year-on-year change?
What is Adverum Biotechnologies annual net profit?
The current annual net income of ADVM is -$117.17 M
What is the all time high annual net income for Adverum Biotechnologies?
Adverum Biotechnologies all-time high annual net profit is -$1.81 M
What is Adverum Biotechnologies annual net income year-on-year change?
Over the past year, ADVM annual net profit has changed by +$37.37 M (+24.18%)
What is Adverum Biotechnologies quarterly net profit?
The current quarterly net income of ADVM is -$27.13 M
What is the all time high quarterly net income for Adverum Biotechnologies?
Adverum Biotechnologies all-time high quarterly net profit is -$49.00 K
What is Adverum Biotechnologies quarterly net income year-on-year change?
Over the past year, ADVM quarterly net profit has changed by +$5.75 M (+17.49%)
What is Adverum Biotechnologies TTM net profit?
The current TTM net income of ADVM is -$94.11 M
What is the all time high TTM net income for Adverum Biotechnologies?
Adverum Biotechnologies all-time high TTM net profit is -$49.00 K
What is Adverum Biotechnologies TTM net income year-on-year change?
Over the past year, ADVM TTM net profit has changed by +$32.08 M (+25.42%)